Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $346.07 | $19.63 | 1,663.30% | 6,921.40x | 102.16x | 7.67x | 9.28x | 6.68x | $529.27M | 1.39% | $4.13B | 37.48 | $36.20B | 113.83 | ||
| NVO | NOVO NORDISK A S | $49.57 | $151.87 | -67.36% | 13.58x | 2.18x | 4.53x | 7.21x | 0.14x | $9.33B | 4.21% | $30.70B | 6.88 | $237.86B | 9.86 | ||
| CORT | CORCEPT THERAPEUTICS INC | $39.97 | $42.41 | -5.76% | 39.97x | 64.59x | 5.58x | 6.65x | 0.41x | $162.57M | 3.93% | $631.90M | 6.10 | $4.09B | 61.92 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.50 | $16.73 | -49.19% | 17.71x | 15.02x | 5.64x | 3.59x | 0.23x | -$23.64M | -4.98% | $133.17M | 2.38 | $486.81M | 7.24 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $45.37 | $18.03 | 151.69% | 92.59x | 28.44x | 5.67x | 6.42x | 1.12x | $101.73M | 3.00% | $535.38M | 7.17 | $3.27B | 61.10 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $314.40 | $108.83 | 188.89% | 131.55x | 46.93x | 11.09x | 52.84x | 1.24x | $465.38M | 1.13% | $789.18M | 6.02 | $43.01B | 68.11 | ||
| VCEL | VERICEL CORP | $35.96 | $9.74 | 269.29% | 138.31x | 63.44x | 7.02x | 5.65x | 1.63x | $20.38M | 1.12% | $321.86M | 6.38 | $1.82B | 61.96 | ||
| ARGX | ARGENX SE | $821.96 | $376.85 | 118.11% | 32.85x | 27.42x | 26,514.84x | 7.00x | 1.33x | $467.72M | 0.93% | $7.17B | 117.50 | $47.76B | 58.87 | ||
| GMAB | GENMAB A | $30.03 | $130.19 | -76.93% | 12.82x | 1.78x | 5.41x | 3.35x | 0.10x | $1.19B | 6.19% | $5.75B | 8.96 | $17.66B | 8.83 | ||
| KRYS | KRYSTAL BIOTECH INC | $276.45 | $121.14 | 128.20% | 40.07x | 33.19x | 21.45x | 7.05x | 1.28x | $166.02M | 2.07% | $1.14B | 39.30 | $7.63B | 39.49 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $183.83 | $73.61 | 149.75% | 79.58x | 21.73x | 14.33x | 3.81x | 1.14x | $30.76M | 0.85% | $950.17M | 48.53 | $3.93B | 38.15 | ||
| TECH | BIO-TECHNE CORP | $59.93 | $16.75 | 257.88% | 115.25x | 29.67x | 7.68x | 4.66x | 1.63x | $223.02M | 2.39% | $2.01B | 12.90 | $9.55B | 42.20 | ||
| ADMA | ADMA BIOLOGICS INC | $16.09 | $12.97 | 24.06% | 18.28x | 17.63x | 7.86x | 8.88x | 0.77x | $40.73M | 1.06% | $431.19M | 1.81 | $3.84B | 22.32 | ||
| MNKD | MANNKIND CORP | $5.66 | $2.98 | 89.62% | 56.60x | 64.83x | 5.53x | -39.01x | 0.88x | $43.39M | 2.49% | -$44.55M | -0.15 | $1.97B | 26.92 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.01 | $19.46 | -74.25% | 3.15x | -92.95x | 715.71x | 1.59x | 0.18x | -$82.36M | -30.30% | $171.23M | 3.16 | $212.38M | 2.36 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.97 | $3.64 | -18.39% | 42.43x | 16.80x | 3.81x | 4.51x | 0.34x | -$11.69M | -4.95% | $52.91M | 0.67 | $233.38M | 26.31 | ||
| RPRX | ROYALTY PHARMA PLC | $45.19 | $48.01 | -5.87% | 25.25x | 8.71x | 8.17x | 2.68x | 0.45x | $2.22B | 11.42% | $9.71B | 22.60 | $34.40B | 31.89 | ||
| VCYT | VERACYTE INC | $35.77 | $12.66 | 182.47% | 91.72x | 31.65x | 5.69x | 2.25x | 1.29x | $98.21M | 3.49% | $1.26B | 15.98 | $2.55B | 44.75 | ||
| XOMA | XOMA ROYALTY CORP | $24.01 | $16.14 | 48.79% | 29.64x | 76.37x | 6.19x | 3.38x | 0.79x | -$12.41M | -4.26% | $87.94M | 7.25 | $338.75M | 12.66 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.14 | $4.40 | 16.76% | 19.04x | 17.08x | 3.29x | 5.80x | 0.68x | $21.15M | 5.16% | $70.68M | 0.89 | $348.97M | 15.38 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.01 | $64.49 | -44.16% | 11.15x | 8.33x | 2.51x | 2.48x | 0.29x | $296.89M | 14.33% | $835.12M | 14.51 | $1.60B | 5.92 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.23 | $10.03 | 41.91% | 24.53x | 14.92x | 7.06x | 5.13x | 0.80x | $119.87M | 6.39% | $365.77M | 2.78 | $1.88B | 18.17 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $21.70 | $6.26 | 246.38% | 62.00x | -18.88x | 2.70x | 6.84x | 1.92x | $78.64M | 2.87% | $401.17M | 3.17 | $2.74B | 29.35 | ||
| HALO | HALOZYME THERAPEUTICS INC | $79.44 | $82.70 | -3.95% | 16.25x | 9.53x | 7.49x | 18.54x | 0.55x | $602.40M | 6.47% | $503.92M | 4.30 | $10.43B | 12.34 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.33 | $23.93 | 1.67% | 13.59x | 13.40x | 5.16x | 3.25x | 0.68x | $234.54M | 7.86% | $920.25M | 7.51 | $2.30B | 7.11 | ||
| CRMD | CORMEDIX INC | $7.34 | $14.80 | -50.41% | 3.23x | 4.51x | 2.60x | 1.55x | 1.81x | $74.42M | 13.35% | $374.13M | 4.93 | $678.74M | 6.05 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $803.17 | $454.38 | 76.76% | 18.65x | 17.29x | 5.86x | 2.72x | 1.48x | $4.08B | 4.86% | $31.26B | 298.82 | $84.50B | 14.52 | ||
| EXEL | EXELIXIS INC | $43.92 | $36.49 | 20.35% | 15.25x | 13.51x | 5.14x | 5.28x | 0.83x | $875.84M | 7.34% | $2.16B | 7.96 | $11.10B | 11.16 | ||
| UTHR | UNITED THERAPEUTICS CORP | $473.66 | $259.79 | 82.33% | 16.63x | 16.07x | 6.63x | 3.09x | 1.90x | $1.12B | 5.41% | $6.59B | 150.46 | $19.05B | 10.75 | ||
| INVA | INNOVIVA INC | $22.70 | $19.75 | 14.92% | 12.01x | 10.39x | 4.03x | 1.68x | 0.98x | $196.54M | 12.54% | $1.01B | 14.63 | $1.48B | 6.88 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $491.47 | $192.04 | 155.92% | 31.79x | 24.11x | 10.47x | 6.69x | 1.81x | $3.19B | 2.54% | $18.67B | 73.00 | $121.61B | 24.99 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.87 | $52.24 | 14.60% | 22.01x | 13.50x | 3.72x | 1.90x | 0.62x | $832.13M | 7.24% | $6.06B | 31.54 | $10.85B | 14.04 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $22.03 | $12.40 | 77.61% | 14.03x | 28.80x | 3.55x | 4.06x | 2.56x | $197.81M | 5.32% | $917.27M | 5.43 | $3.50B | 12.17 | ||
| MDXG | MIMEDX GROUP INC | $5.12 | $2.73 | 87.37% | 18.29x | 45.63x | 1.93x | 3.17x | 1.75x | $66.82M | 8.81% | $238.95M | 1.61 | $634.41M | 9.17 | ||
| INCY | INCYTE CORP | $101.10 | $76.59 | 32.00% | 15.34x | 12.63x | 3.84x | 3.89x | 0.99x | $1.35B | 6.86% | $5.17B | 26.47 | $17.06B | 9.69 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.